US 11884919
Lipid formulated compositions and methods for inhibiting expression of serum amyloid a gene
granted A61KA61K31/713A61P
Quick answer
US patent 11884919 (Lipid formulated compositions and methods for inhibiting expression of serum amyloid a gene) held by Alnylam Pharmaceuticals, Inc. expires Mon Jan 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Jan 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/713, A61P, A61P1/00, A61P1/04